Regulation of mRNA translation as a conserved mechanism of longevity control

Advances in Experimental Medicine and Biology

Volumn 694, Issue , 2010, Pages 14-29

  Mehta, Ranjana ^b   Chandler Brown, Devon ^b   Ramos, Fresnida J ^b   Shamieh, Lara S ^b   Kaeberlein, Matt ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; RAPAMYCIN DERIVATIVE;

ARTICLE; CAENORHABDITIS ELEGANS; CANCER GENETICS; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL SURVIVAL; DEGENERATIVE DISEASE; DIABETOGENESIS; DROSOPHILA MELANOGASTER; ENERGY BALANCE; EUKARYOTE; FUNGAL GENOME; GENETIC CONSERVATION; GENOME ANALYSIS; GERIATRIC DISORDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESPAN; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MOLECULAR EVOLUTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN SYNTHESIS; RNA INTERFERENCE; SACCHAROMYCES CEREVISIAE; TRANSLATION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; NUCLEOTIDE SEQUENCE; REVIEW; RNA PROCESSING;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; EUKARYOTA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

ANIMALS; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; LONGEVITY; PROTEIN BIOSYNTHESIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 78049393738     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7002-2_2     Document Type: Article

References (133)

1. Bohr VA, Anson RM. DNA damage, mutation and fine structure DNA repair in aging. Mutat Res 1995; 338:25-34.
2. de Magalhaes JP, Faragher RG. Cell divisions and mammalian aging: integrative biology insights from genes that regulate longevity. Bioessays 2008; 30:567-78. (Pubitemid 351859413)
3. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008; 129:467-74.
4. Morimoto RI, Cuervo AM. Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci 2009; 64:167-70.
5. Ramasamy R, Vannucci SJ, Yan SS et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiology 2005; 15:16R-28R. (Pubitemid 41417992)
6. Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science 1996; 273:59-63. (Pubitemid 26255420)
7. Warner HR. Superoxide dismutase, aging and degenerative disease. Free Radic Biol Med 1994; 17:249-58. (Pubitemid 24269677)
8. Kaeberlein M. Genome-wide approaches to understanding human ageing. Hum Genomics 2006; 2:422-8. (Pubitemid 44110988)
9. Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev 2005; 126:913-22. (Pubitemid 41033171)
10. Weindruch RH, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. (Thomas, Springfield, IL., 1988).
11. Colman RJ, Beasley TM, Allison DB et al. Attenuation of sarcopenia by dietary restriction in rhesus monkeys. J Gerontol A Biol Sci Med Sci 2008; 63:556-9.
12. Ingram DK, Young J, Mattison JA. Calorie restriction in nonhuman primates: assessing effects on brain and behavioral aging. Neuroscience 2007; 145:1359-64. (Pubitemid 46602737)
13. Messaoudi I, Warner J, Fischer M et al. Delay of T-cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci USA 2006; 103:19448-53. (Pubitemid 46026051)
14. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009; 325:201-4.
15. Hansen M, Taubert S, Crawford D et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 2007; 6:95-110. (Pubitemid 46140143)
16. Kaeberlein M, Powers RW 3rd, Steffen KK et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 2005; 310:1193-6. (Pubitemid 41681747)
17. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471-84. (Pubitemid 43199434)
18. Hansen M, Chandra A, Mitic LL et al. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet 2008; 4:e24.
19. Jia K, Levine B. Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007; 3:597-9. (Pubitemid 350060057)
20. Meléndez A, Tallóczy Z, Seaman M et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301:1387-91. (Pubitemid 37075816)
21. Kaeberlein M, Kennedy BK. Protein translation, 2007. Aging Cell 2007; 6:731-4.
22. Winzeler EA, Shoemaker DD, Astromoff A et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999; 285:901-6. (Pubitemid 29381993)
23. Kaeberlein M, Kennedy BK. Large-scale identification in yeast of conserved ageing genes. Mech Ageing Dev 2005; 126:17-21. (Pubitemid 40018473)
24. Powers RW 3rd, Kaeberlein M, Caldwell SD et al. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174-84. (Pubitemid 43112936)
25. Kaeberlein M. in Handbook of models for human aging (ed. Conn, P.M.) 109-120 (Elsevier Press, Boston, 2006).
26. Fabrizio P, Longo VD. The chronological life span of Saccharomyces cerevisiae. Aging Cell 2003; 2:73-81.
27. Ashrafi K, Sinclair D, Gordon JI et al. Passage through stationary phase advances replicative aging in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1999; 96:9100-5. (Pubitemid 29374714)
28. Jazwinski SM. Molecular mechanisms of yeast longevity. Trends Microbiol 1999; 7:247-52. (Pubitemid 29317306)
29. Jazwinski SM. Yeast longevity and aging-the mitochondrial connection. Mech Ageing Dev 2005; 126:243-8. (Pubitemid 40038344)
30. Steinkraus KA, Kaeberlein M, Kennedy BK. Replicative aging in yeast: the means to the end. Annu Rev Cell Dev Biol 2008; 24:29-54.
31. Kamath RS, Fraser AG, Dong Y et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003; 421:231-7. (Pubitemid 36139121)
32. Rual JF, Ceron J, Koreth J et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 2004; 14:2162-8. (Pubitemid 39440199)
33. Chen D, Pan KZ, Palter JE et al. Longevity determined by developmental arrest genes in Caenorhabditis elegans. Aging Cell 2007; 6:525-33. (Pubitemid 47087057)
34. Curran SP, Ruvkun G. Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet 2007; 3:e56.
35. Dillin A, Hsu AL, Arantes-Oliveira N et al. Rates of behavior and aging specified by mitochondrial function during development. Science 2002; 298:2398-401. (Pubitemid 36014215)
36. Hamilton B et al. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev 2005; 19:1544-55. (Pubitemid 41002998)
37. Hansen M, Hsu AL, Dillin A et al. New genes tied to endocrine, metabolic and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet 2005; 1:119-28.
38. Lee SS et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 2003; 33:40-8. (Pubitemid 36068680)
39. Jia K, Chen D, Riddle DL. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004; 131:3897-906. (Pubitemid 39232150)
40. Vellai T, Takacs-Vellai K, Zhang Y et al. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003; 426:620. (Pubitemid 38009359)
41. Fabrizio P, Pletcher SD, Minois N et al. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett 2004; 557:136-42. (Pubitemid 38115884)
42. Fabrizio P, Pozza F, Pletcher SD et al. Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001; 292:288-90. (Pubitemid 32295387)
43. Kapahi P, Zid BM, Harper T et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004; 14:885-90. (Pubitemid 38800910)
44. Pan KZ, Palter JE, Rogers AN et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111-9. (Pubitemid 46140144)
45. Syntichaki P, Troulinaki K, Tavernarakis N. eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 2007; 445:922-6.
46. Chiocchetti A, Zhou J, Zhu H et al. Ribosomal proteins Rpl10 and Rps6 are potent regulators of yeast replicative life span. Exp Gerontol 2006.
47. Managbanag JR, Witten TM, Bonchev D et al. Shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity. PLoS ONE 2008; 3:e3802.
48. Steffen KK, MacKay VL, Kerr EO et al. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 2008; 133:292-302. (Pubitemid 351508304)
49. Smith ED, Tsuchiya M, Fox LA et al. Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res 2008; 18:564-70. (Pubitemid 351482781)
50. Urban J, Soulard A, Huber A et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell 2007; 26:663-74. (Pubitemid 46856238)
51. Chiocchetti A, Zhou J, Zhu H et al. Ribosomal proteins Rpl10 and Rps6 are potent regulators of yeast replicative life span. Exp Gerontol 2007; 42:275-86. (Pubitemid 46356851)
52. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000; 289:2126-8.
53. Lin SJ et al. Calorie restriction extends Saccharomyces cerevisiae life span by increasing respiration. Nature 2002; 418:344-48.
54. Jiang JC, Jaruga E, Repnevskaya MV et al. An intervention resembling caloric restriction prolongs life span and retards aging in yeast. FASEB J 2000; 14:2135-7.
55. Kaeberlein M, Kirkland KT, Fields S et al. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2004; 2:E296.
56. Kaeberlein TL, Smith ED, Tsuchiya M et al. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 2006.
57. Lee GD, Wilson MA, Zhu M et al. Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell 2006.
58. Greer EL, Brunet A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 2009; 8:113-27.
59. Avruch J, Hara K, Lin Y et al. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 2006; 25:6361-72. (Pubitemid 44596154)
60. Mehta R, Steinkraus KA, Sutphin GL et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 2009.
61. Juhasz G, Erdi B, Sass M et al. Atg7-dependent autophagy promotes neuronal health, stress tolerance and longevity but is dispensable for metamorphosis in Drosophila. Genes Dev 2007; 21:3061-6. (Pubitemid 350223523)
62. Morck C, Pilon M. C. elegans feeding defective mutants have shorter body lengths and increased autophagy. BMC Dev Biol 2006; 6:39.
63. Takeshige K, Baba M, Tsuboi S et al. Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol 1992; 119:301-11.
64. Hinnebusch AG. Translational regulation of yeast GCN4. A window on factors that control initiator-trna binding to the ribosome. J Biol Chem 1997; 272:21661-4. (Pubitemid 27382774)
65. Yang R, Wek SA, Wek RC. Glucose limitation induces GCN4 translation by activation of Gcn2 protein kinase. Mol Cell Biol 2000; 20:2706-17. (Pubitemid 30183489)
66. Shimizu YI, Morita M, Ohmi A et al. Fasting induced up-regulation of activating transcription factor 5 in mouse liver. Life Sci 2009.
67. Zhou D, Palam LR, Jiang L et al. Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J Biol Chem 2008; 283:7064-73.
68. Bilanges B, Argonza-Barrett R, Kolesnichenko M et al. Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol Cell Biol 2007; 27:5746-64. (Pubitemid 47257831)
69. Balch WE, Morimoto RI, Dillin A et al. Adapting proteostasis for disease intervention. Science 2008; 319:916-9. (Pubitemid 351263754)
70. Cohen E, Bieschke J, Perciavalle RM et al. Opposing activities protect against age-onset proteotoxicity. Science 2006; 313:1604-10. (Pubitemid 44414028)
71. Hsu AL, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003; 300:1142-5. (Pubitemid 36583098)
72. Morley JF, Morimoto RI. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell 2004; 15:657-64. (Pubitemid 38146482)
73. Steinkraus KA, Smith ED, Davis C et al. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell 2008.
74. Ravikumar B, Vacher C, Berger Z et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36:585-95. (Pubitemid 38715985)
75. King MA, Hands S, Hafiz F et al. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol Pharmacol 2008; 73:1052-63. (Pubitemid 351439187)
76. Barbet NC, Schneider U, Helliwell SB et al. TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 1996; 7:25-42. (Pubitemid 26033647)
77. Dennis PB, Fumagalli S, Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 1999; 9:49-54. (Pubitemid 29080386)
78. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005; 6:318-27. (Pubitemid 40516898)
79. Barnes AI, Partridge L. Costing reproduction. Animal Behaviour 2003; 66:199-204. (Pubitemid 36990302)
80. Kenyon C. The plasticity of aging: Insights from long-lived mutants. Cell 2005; 120:449-460. (Pubitemid 40269760)
81. Friberg J. in Umea Centre for Molecular Pathogenesis 39 (Umea University, Umea, 2006).
82. Pan KZ, Palter JE, Rogers AN et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111-119. (Pubitemid 46140144)
83. Jastrzebski K, Hannan KM, Tchoubrieva EB et al. Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 2007; 25:209-26.
84. Weindruch R, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. Springfield: Charles C. Thomas, 1988.
85. Spindler SR. Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction. Mech Ageing Dev 2005; 126:960-6. (Pubitemid 41033176)
86. Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med 2005; 11:353-61. (Pubitemid 41080576)
87. Sampson JR, Patel A, Mee AD. Multifocal renal cell carcinoma in sibs from a chromosome 9 linked (TSC1) tuberous sclerosis family. J Med Genet 1995; 32:848-50.
88. Al-Saleem T, Wessner LL, Scheithauer BW et al. Malignant tumors of the kidney, brain and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998; 83:2208-16. (Pubitemid 28525404)
89. Daido S, Yamamoto A, Fujiwara K et al. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 2005; 65:4368-75. (Pubitemid 40775676)
90. Mita MM, Mita AC, Chu QS et al. Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies. J Clin Oncol 2008; 26:361-7. (Pubitemid 351171685)
91. Yamamoto S, Tomita Y, Hoshida Y et al. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. Clin Cancer Res 2004; 10:2846-50. (Pubitemid 38509164)
92. Vasko V, Saji M, Hardy E et al. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet 2004; 41:161-70. (Pubitemid 38333792)
93. Zhou BP, Liao Y, Xia W et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-52. (Pubitemid 32201319)
94. Faried LS, Faried A, Kanuma T et al. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep 2006; 16:57-63.
95. Blando J, Portis M, Benavides F et al. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am J Pathol 2009; 174:1869-79.
96. Ebi H, Tomida S, Takeuchi T et al. Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res 2009; 69:4027-35.
97. Kim SH, Zukowski K, Novak RF. Rapamycin effects on mTOR signaling in benign, premalignant and malignant human breast epithelial cells. Anticancer Res 2009; 29:1143-50.
98. Meier F, Guenova E, Clasen S et al. Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients. J Am Acad Dermatol 2009; 60:863-8.
99. Raimondi AR, Molinolo A, Gutkind JS. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 2009; 69:4159-66.
100. McDaniel ML, Marshall CA, Pappan KL et al. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic beta-cells. Diabetes 2002; 51:2877-85.
101. Briaud I, Dickson LM, Lingohr MK et al. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 2005; 280:2282-93.
102. Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.J Cell Biol 2004; 167:399-403. (Pubitemid 39489047)
103. Harrington LS, Findlay GM, Gray A et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 2004; 166:213-23. (Pubitemid 38988774)
104. Pende M, Kozma SC, Jaquet M et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000; 408:994-7. (Pubitemid 32103292)
105. Um SH, Frigerio F, Watanabe M et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431:200-5. (Pubitemid 39243474)
106. Tsukiyama-Kohara K, Poulin F, Kohara M et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 2001; 7:1128-32. (Pubitemid 33010021)
107. Cho HJ, Park J, Lee HW et al. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 2004; 321:942-8. (Pubitemid 39055987)
108. Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004; 53:2748-56. (Pubitemid 39425899)
109. Polak P, Cybulski N, Feige JN et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399-410.
110. Guertin DA, Stevens DM, Thoreen CC et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 2006; 11:859-71. (Pubitemid 44804279)
111. Bentzinger CF, Romanino K, Cloëtta D et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008; 8:411-24.
112. Shioi T, McMullen JR, Tarnavski O et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003; 107:1664-70. (Pubitemid 36397337)
113. Sanada S, Node K, Asanuma H et al. Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. J Am Coll Cardiol 2002; 40:991-7. (Pubitemid 34994997)
114. Gao XM, Wong G, Wang B et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006; 24:1663-70. (Pubitemid 44162470)
115. Gillette-Guyonnet S, Vellas B. Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care 2008; 11:686-92.
116. Levenson CW, Rich NJ. Eat less, live longer? New insights into the role of caloric restriction in the brain. Nutr Rev 2007; 65:412-5. (Pubitemid 351804349)
117. Malagelada C, Jin ZH, Greene LA. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci 2008; 28:14363-71.
118. Millino C, Fanin M, Vettori A et al. Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med 2009; 7:14.
119. Sarkar S, Ravikumar B, Rubinsztein DC. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Methods Enzymol 2009; 453:83-110.
120. Bonini NM, La Spada AR. Silencing polyglutamine degeneration with RNAi. Neuron 2005; 48:715-8. (Pubitemid 41759422)
121. Cheng-Lai A, Frishman WH. Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease. Am J Ther 2004; 11:218-28.
122. Weil RJ. Incorporating molecular tools into early-stage clinical trials. PLoS Med 2008; 5:e21.
123. Miller RA, Harrison DE, Astle CM et al. An aging interventions testing program: study design and interim report. Aging Cell 2007; 6:565-75. (Pubitemid 47087061)
124. Syntichaki P, Troulinaki K, Tavernarakis N. Protein synthesis is a novel determinant of aging in Caenorhabditis elegans. Ann N Y Acad Sci 2007; 1119:289-95. (Pubitemid 350191220)
125. Tavernarakis N. Ageing and the regulation of protein synthesis: a balancing act? Trends Cell Biol 2008; 18:228-35.
126. Kim Y, Sun H. Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan. Aging Cell 2007; 6:489-503. (Pubitemid 47087054)
127. Gangloff YG, Mueller M, Dann SG et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 2004; 24:9508-16. (Pubitemid 39391687)
128. Murakami M, Ichisaka T, Maeda M et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 2004; 24:6710-8. (Pubitemid 38944350)
129. Shima H, Pende M, Chen Y et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17:6649-59. (Pubitemid 28521798)
130. Pende M, Um SH, Mieulet V et al. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin- sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 2004; 24:3112-24. (Pubitemid 38452057)
131. Gandin V, Miluzio A, Barbieri AM et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008; 455:684-8.
132. Le Bacquer O, Petroulakis E, Paglialunga S et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007; 117:387-96. (Pubitemid 46203967)
133. Anderson SJ, Lauritsen JP, Hartman MG et al. Ablation of ribosomal protein L22 selectively impairs alphabeta T-cell development by activation of a p53-dependent checkpoint. Immunity 2007; 26:759-72. (Pubitemid 46907667)